Brief: Impact Biomedical To Begin Efficacy Testing Of Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary - Innate Immune Inc

DSS

01/10/2020 13:59

Oct 1 (Reuters) - Document Security Systems Inc  DSS.A :
    * IMPACT BIOMEDICAL TO BEGIN EFFICACY TESTING OF
PAN-CORONAVIRUS
VACCINE UNDER NEW WHOLLY OWNED SUBSIDIARY - INNATE IMMUNE, INC.

Source text for Eikon:  ID:nGNX6BzPXj 
Further company coverage:  DSS.A 

 ((Reuters.Briefs@thomsonreuters.com;))